Pharmaceutical R&D is falling increasingly to artificial intelligence (AI)-guided autonomous laboratories, and the people behind them say the role of human researchers may soon be transformed but not ...

Taking a cue from the automotive industry, the biopharma sector has been increasingly focused on autonomous capabilities as a means towards improved accuracy, reproducibility, and efficiency in ...

BOSTON, Feb. 5, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI system that autonomously designed, executed, and learned from ...

After reporting weak results again in the fourth quarter, Ginkgo Bioworks announced another strategic pivot, which includes divesting its biosecurity business. Ginkgo is focusing on autonomous labs, ...

The modern research and development landscape is undergoing a significant transformation. For decades, scientific discovery in the life sciences and materials industries has relied heavily on manual ...

Scientists are building autonomous robotic labs powered by artificial intelligence. The goal, they say, is for these robots to take over human... Scientists in 'autonomous laboratories' are starting ...

"In 2026, our focus will be on investing to win the category of autonomous labs" (CEO Jason Kelly), adding that Ginkgo’s two main actions are "to take our services...and run them on top of our ...

Rigoberto “Gobet” Advincula, Oak Ridge National Laboratory–University of Tennessee (UT-ORNL) Governor’s Chair Professor and leader of ORNL’s Macromolecular Nanomaterials Group. In a recent webinar ...

Nearly two decades ago, four graduate students from MIT united around a shared idea. "We believed that programming cells would ultimately be more important than programming computers," says Jason ...